+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 65Years +
All Genders
ID07795398

DAN-RELEASE Trial Evaluating Long-Term Aspirin Use in Older Adults with Stable Ischemic Heart Disease

Led by Odense University Hospital · Updated on 2026-10-05

7000

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying older adults with stable ischemic heart disease to determine if stopping long-term aspirin therapy is as safe and effective as continuing it. The trial focuses on adults aged 65 and older who have been free from heart-related events for at least two years after a heart attack or heart procedures. This study is a national, randomized trial conducted in Denmark and aims to address whether lifelong aspirin treatment is necessary given the risks of bleeding in older age. Participants are assigned to one of two groups one group continues their daily low-dose aspirin therapy, while the other group stops taking aspirin. The study uses nationwide health registries to collect data and includes questionnaires to assess bleeding symptoms, gastrointestinal discomfort, quality of life, and lifestyle behaviors. The trial follows participants for at least one year to monitor outcomes. During the study, participants will be monitored for cardiovascular and bleeding events, including heart attacks, strokes, and various types of bleeding. Questionnaires will be completed at the start and at 3, 6, 12, and 24 months after starting the study to evaluate symptoms and quality of life. The study aims to gather comprehensive information about the effects of continuing versus stopping aspirin in this population, with follow-up continuing until the end of the trial, which is expected in 2029.

CONDITIONS

Brief Title

DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease

Research Team

A

Axel Diederichsen, Professor

E

Eva Prescott, Professor

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here